DP2 Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AH-6809 | 33458-93-4 | sc-201342 sc-201342A | 5 mg 25 mg | $71.00 $288.00 | 2 | |
AH-6809 acts as a selective antagonist for the DP2 receptor, characterized by its ability to disrupt the receptor-ligand interaction through competitive binding. Its unique structural conformation allows for specific steric hindrance, effectively blocking downstream signaling pathways. The compound exhibits distinct kinetic properties, influencing the rate of receptor activation and desensitization. Furthermore, its solubility profile enhances its interaction dynamics within biological systems, impacting overall receptor functionality. | ||||||
2-[3-[(4-fluorophenyl)sulfonyl-methylamino]-1,2,3,4-tetrahydrocarbazol-9-yl]acetic acid) | 627865-18-3 | sc-221402 sc-221402A | 1 mg 5 mg | $81.00 $487.00 | ||
2-[3-[(4-fluorophenyl)sulfonyl-methylamino]-1,2,3,4-tetrahydrocarbazol-9-yl]acetic acid demonstrates remarkable selectivity for the DP2 receptor, engaging in unique hydrogen bonding and hydrophobic interactions that stabilize its binding. This compound's intricate molecular architecture facilitates a distinct allosteric modulation of receptor activity, altering conformational states and influencing downstream signaling cascades. Its dynamic solubility characteristics further enhance its interaction with lipid membranes, affecting membrane fluidity and receptor accessibility. | ||||||
BAY-u 3405 | 116649-85-5 | sc-203834 sc-203834A | 10 mg 50 mg | $193.00 $813.00 | ||
BAY-u 3405 exhibits a distinctive profile as a DP2 receptor antagonist, characterized by its ability to form strong π-π stacking interactions with aromatic residues in the receptor binding site. This compound's unique steric configuration promotes selective binding, leading to altered receptor conformations that modulate signaling pathways. Additionally, its lipophilic nature enhances membrane permeability, facilitating rapid distribution and interaction with cellular targets, thereby influencing biological responses. | ||||||
5-chloro-1′-[(2-fluorophenyl)methyl]-2,2′,5′-trioxo-spiro[3H-indole-3,3′-pyrrolidine-1(2H)-acetic acid | 916046-55-4 | sc-205132 sc-205132A | 1 mg 5 mg | $70.00 $320.00 | ||
5-chloro-1'-[(2-fluorophenyl)methyl]-2,2',5'-trioxo-spiro[3H-indole-3,3'-pyrrolidine-1(2H)-acetic acid demonstrates intriguing reactivity as an acid halide, engaging in nucleophilic acyl substitution with high efficiency. Its spirocyclic structure introduces unique steric hindrance, affecting reaction kinetics and selectivity. The presence of halogen atoms enhances electrophilicity, promoting interactions with nucleophiles, while the compound's rigid framework contributes to its stability in various chemical environments. | ||||||
CAY10595 | 916047-16-0 | sc-223875 sc-223875A | 1 mg 5 mg | $106.00 $480.00 | ||
CAY10595, characterized by its spirocyclic architecture, exhibits remarkable reactivity as a DP2 acid halide. The compound's unique conformation facilitates selective interactions with nucleophiles, leading to accelerated reaction rates. Its halogen substituents significantly enhance electrophilic character, allowing for diverse acylation pathways. Additionally, the compound's structural rigidity imparts stability, influencing its behavior in various solvent systems and reaction conditions. | ||||||
11-keto Fluprostenol | 62145-07-7 | sc-220576 sc-220576A | 1 mg 5 mg | $87.00 $391.00 | ||
11-keto Fluprostenol, a notable DP2 acid halide, features a distinctive carbon framework that promotes specific stereoelectronic interactions. This compound demonstrates a propensity for rapid acyl transfer reactions, driven by its highly polarized carbonyl group. The presence of functional groups enhances its reactivity, allowing for selective binding with various nucleophiles. Its unique spatial arrangement also influences solvation dynamics, affecting its behavior in different chemical environments. | ||||||